Comments
Onco Therapies Ltd, a wholly owned subsidiary of Strides Arcolab Ltd, has received final Abbreviated New Drug Application (ANDA) approval for Venorelbine injection USP, 10 mg/ml packaged in 10 mg/1 ml and 50 mg/5ml single dose vials.
Venorelbine is a part of the oncology portfolio licensed to Pfizer for the US market and the product is available for immediate launch.
The drug is used to treat various types of cancer. It is a chemotherapy drug that works by slowing or stopping cancer cell growth.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.